SoCalBio Boot Camp

SoCalBio Boot Camp for Emerging Companies 

Learn What it Takes to Build a Fundable and Viable Company

Offered Virtually
September 15, 16, and 17, 2020
From 1:00 PM to 4:00 PM (PDT) each day

SoCalBio Boot Camp

Download Event Brochure Here!

This Boot Camp is offered by the SoCalBio Innovation Catalyst Program. It is designed for biotech, device, Dx and digital health companies. The Boot Camp will provide emerging entrepreneurs and innovators with an in-depth understanding of what it takes to raise earlystage capital and/or forge partnerships. Issues covered run the whole gamut from making effective presentations to negotiating term sheets.

THANKS TO LEADING SPONSORS

Agenda

DAY ONE

Tuesday, September 15, 2020

1:00 PM Welcoming remarks and acknowledgment of partners
  • Ahmed Enany, President & CEO, SoCalBio
1:10 PM SoCalBio staff will lead a demonstration of the platform to be used in the live streaming of company presentations during the Annual SoCalBio Conference on Oct. 21-23, 2020
  • Equipment, Browsers & Internet connection
  • Managing Q/A during the event
  • Scheduling one-on-one meetings
  • Setting up meet-up rooms to interface with interested investors and potential partners
2:00 PM Q/A
2:15 PM The elements of an effective investor pitch
  • Sasha Strauss, Managing Partner, Innovation Protocol
2:35 PM What not to do when pitching remotely
  • Erik Deutsch, Principal, Excel PR Group
2:55 PM Q/A
3:15 PM Company presentation practice-run with audience commentary
4:00 PM Meeting adjourns

DAY TWO

Wednesday, September 16, 2020

1:00 PMIntroductory remarks
1:05 PMUnderstand the risk profile of your venture and how it impacts financing
  • IP risks: Michael Wise, Partner, Perkins Coie
  • Strategy risks: William Dolphin, PhD, CEO, CueSquared
  • Regulatory risks: Evan Siegel, PhD, Ground Zero Pharmaceuticals
1:50 PMQ/A
2:10 PMPlanning your fund-raising campaign. Where to find
the money in Southern California and elsewhere.
  • Ahmed Enany, President & CEO, SoCalBio
2:45 PMQ/A
3:00 PMWhat’s it worth? Understanding the valuation of early-stage, pre-revenue bioscience firms
  • John Greenway, Principal, Trinity (invited)
  • Pankaj Singhal, President & CEO, NurtureX
3:45 PMQ/A
4:00 PMThe Art of negotiating term sheets
  • George Colindres, Sr. Counsel, Perkins Coie
  • Thomas Stromberg, Partner, Perkins Coie
4:45 PMQ/A
5:00 PMMeeting adjourns

DAY THREE

Thursday, September 17, 2020

1:00 PMIntroductory remarks
1:05 PMMaking your company fundable. What investors look for?
  • Kwame Ulmer, Venture Partner, Wavemaker Three-Sixty Health
  • Chris Bostick, PhD, VP, OCV Partners
  • Roger Zickfeld, Managing Director, Columbia Capital
1:50 PMQ/A
2:00 PMPanel discussion:Four entrepreneurs who raised significant funding for their companies share insights on maximizing your chances of securing angel, strategic, and institutional deals:
  • Bruce Bauer, PhD, President & CEO, TAE Life Sciences
  • Basil Dahiyat, PhD, President & CEO, Xencor
  • Robert Hamilton, PhD, CSO, NovaSignal
  • Frank Watanabe, CEO, Arcutis Biotherapeutics
3:00 PMQ/A
3:15 PMCompany presentation practice-run with audience commentary
3:55 PMConcluding remarks
4:00 PMMeeting adjourns